New Drugs
| Brand/Generic | Company | Description |
|---|---|---|
|
Cablivi caplacizumab-yhdp Click here for more information |
Ablynx U.S. | A von Willebrand factor-directed antibody fragment for treatment of acquired thrombotic thrombocytopenic purpura (aTTP). |
|
Egaten triclabendazole Click here for more information |
Novartis | An oral anthelmintic for treatment of fascioliasis. |
|
Evenity romosozumab-aqqg Click here for more information |
Amgen | A sclerostin inhibitor for treatment of postmenopausal osteoporosis in patients at high risk for fracture. |
|
Herceptin Hylecta trastuzumab/hyaluronidase-oysk Click here for more information |
Genentech | A subcutaneous injection formulation for HER2-overexpressing breast cancer. |
|
Jeuveau prabotulinumtoxin A-xvfs |
Evolus | A botulinum toxin product to improve the appearance of frown lines between the eyebrows. |
|
Mayzent siponimod Click here for more information |
Novartis | An oral tablet formulation for relapsing forms of multiple sclerosis. |
|
Ontruzant trastuzumab-dttb |
Merck | A biosimilar to Herceptin for breast cancer and gastric/gastroesophageal junction cancer. |
|
Spravato esketamine Click here for more information |
Janssen | An NMDA receptor antagonist nasal spray for treatment-resistant depression. |
|
Sunosi solriamfetol Click here for more information |
Jazz Pharm. | A dopamine and norepinephrine reuptake inhibitor (DNRI) for excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea. |
|
Trazimera trastuzumab-qyyp Click here for more information |
Pfizer | A biosimilar to Herceptin for breast cancer and gastric/gastroesophageal junction cancer. |
|
Zulresso brexanolone Click here for more information |
Sage Therapeutics | An injectable medication for treatment of postpartum depression. |
| Brand/Generic | Company | Description |
|---|---|---|
|
Adhansia XR methylphenidate Click here for more information |
Purdue Pharma | New extended-release formulation for ADHD. |
|
Avaclyr acyclovir |
Fera Pharm. | An ophthalmic ointment for acute herpetic keratitis. |
|
Duaklir Pressair aclidinium/formoterol Click here for more information |
AstraZeneca | A combination anticholinergic and long-acting beta-agonist oral inhaler for COPD. |
|
Gloperba colchicine Click here for more information |
Romeg Therapeutics | A new oral solution formulation for prevention of gout flares in adults. |
|
Jatenzo testosterone undecanoate Click here for more information |
Clarus Therapeutics | An oral androgen for testosterone replacement therapy. |
|
Lotemax SM loteprednol etabonate Click here for more information |
Bausch + Lomb | New 0.38% steroid ophthalmic gel formulation to improve absorption. For post-op inflammation/pain following ocular surgery. |
|
Mavenclad cladribine Click here for more information |
EMD Serono | New tablet formulation for treatment of relapsing forms of multiple sclerosis. |
|
Rocklatan netarsudil/latanoprost Click here for more information |
Aerie Pharm. | New combination Rho kinase inhibitor and prostaglandin analogue to reduce intraocular pressure. |
|
Tosymra sumatriptan Click here for more information |
Promius Pharma | New 10 mg nasal spray formulation for acute migraine. |
|
Zykadia ceritinib Click here for more information |
Novartis | New tablet formulation for metastatic non-small cell lung cancer. |
| Brand/Generic | Company | Description |
|---|